نتائج البحث - Ghassan El‐Haddad
- يعرض 1 - 11 نتائج من 11
-
1
-
2
-
3
-
4
Risk of Bowel Obstruction in Patients with Mesenteric or Peritoneal Disease Receiving Peptide Receptor Radionuclide Therapy حسب Jonathan Strosberg, Taymeyah Al‐Toubah, Eleonora Pellè, J. Joshua Smith, Mintallah Haider, Tai Hutchinson, Jason B. Fleming, Ghassan El‐Haddad
منشور في 2020Artigo -
5
Development of Targeted Alpha Particle Therapy for Solid Tumors حسب Narges K. Tafreshi, Michael Doligalski, Christopher J. Tichacek, Darpan N. Pandya, Mikalai M. Budzevich, Ghassan El‐Haddad, Nikhil I. Khushalani, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas, David L. Morse
منشور في 2019Revisão -
6
NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy حسب Thomas A. Hope, Lisa Bodei, Jennifer A. Chan, Ghassan El‐Haddad, Nicholas Fidelman, Pamela L. Kunz, Josh Mailman, Yusuf Menda, David C. Metz, Erik Mittra, Daniel A. Pryma, Diane Reidy‐Lagunes, Simron Singh, Jonathan Strosberg
منشور في 2020Artigo -
7
Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine... حسب Jennifer R. Eads, Þorvarður R. Hálfdánarson, Tim Asmis, Andrew M Belizzi, Emily K. Bergsland, Arvind Dasari, Ghassan El‐Haddad, Michael Frumovitz, Joshua E. Meyer, Erik Mittra, Sten Myrehaug, Eric K. Nakakura, Nitya Raj, Heloisa P. Soares, Brian R. Untch, Namrata Vijayvergia, Jennifer A. Chan
منشور في 2023Artigo -
8
Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study حسب Alexandra Gangi, Jehan L. Shah, Nathan Hatfield, J. Joshua Smith, Jennifer Sweeney, Junsung Choi, Ghassan El‐Haddad, B. Biebel, Nainesh Parikh, Bülent Arslan, Sarah E. Hoffe, Jessica M. Frakes, Gregory M. Springett, Daniel A. Anaya, Mokenge P. Malafa, Dung‐Tsa Chen, Yunyun Chen, Richard D. Kim, Ravi Shridhar, Béla Kis
منشور في 2018Artigo -
9
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer حسب Oliver Sartor, Johann S. de Bono, Kim N., Karim Fizazi, Ken Herrmann, Kambiz Rahbar, Scott T. Tagawa, Luke T. Nordquist, Nitin Vaishampayan, Ghassan El‐Haddad, Chandler H. Park, Tomasz M. Beer, Alison Armour, Wendy J. Pérez-Contreras, Michelle DeSilvio, Euloge Kpamegan, Germo Gericke, Richard A. Messmann, Michael J. Morris, Bernd J. Krause
منشور في 2021Artigo -
10
Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma حسب Narges K. Tafreshi, Christopher J. Tichacek, Darpan N. Pandya, Michael Doligalski, Mikalai M. Budzevich, HyunJoo Kil, Nikunj Bhatt, Nancy D. Kock, Jane L. Messina, Epifanio Ruiz, Nella C. Delva, Adam Weaver, William R. Gibbons, David Boulware, Nikhil I. Khushalani, Ghassan El‐Haddad, Pierre L. Triozzi, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas, David L. Morse
منشور في 2019Artigo -
11
Phase 3 Trial of <sup>177</sup>Lu-Dotatate for Midgut Neuroendocrine Tumors حسب Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin, Andrew Hendifar, James C. Yao, Beth Chasen, Erik Mittra, Pamela L. Kunz, Matthew H. Kulke, Heather A. Jacene, David Bushnell, Thomas M. O’Dorisio, Richard P. Baum, Harshad Kulkarni, Martyn Caplin, Rachida Lebtahi, Timothy J. Hobday, Ebrahim S. Delpassand, Eric Van Cutsem, Al B. Benson, Rajaventhan Srirajaskanthan, Marianne Pavel, Jaime Font de Mora, Jordan Berlin, Enrique Grande, Nicholas S. Reed, Ettore Seregni, Kjell Öberg, Maribel Lopera Sierra, Paola Santoro, Thomas Thevenet, Jack L. Erion, Philippe Ruszniewski, Dik J. Kwekkeboom, Eric P. Krenning
منشور في 2017Artigo
أدوات البحث:
موضوعات ذات صلة
Medicine
Internal medicine
Cancer research
Oncology
Cancer
Chemistry
Neuroendocrine tumors
Prostate cancer
Radionuclide therapy
Disease
Gastroenterology
Pathology
Biochemistry
Hormone
In vitro
Intensive care medicine
Medical physics
Nuclear medicine
Organic chemistry
Pharmacology
Physics
Prostate
Somatostatin
Somatostatin receptor
Somatostatin receptor 2
Abdomen
Acromegaly
Adverse effect
Alpha particle
Antibody